"Tissue" transglutaminase in AIDS

Journal of Immunological Methods

Volumn 265, Issue 1-2, 2002, Pages 145-159

  Amendola, Alessandra ^a   Fesus, Laszlo ^b   Piacentini, Mauro ^a,c   Szondy, Zsuzsa ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

( glutamyl)lysine; Activation induced cell death; Apoptosis; Bcl 2; EIF5A; HIV infection; Protein cross links; Tissue transglutaminase

Indexed keywords

6 (GAMMA GLUTAMYL)LYSINE; APOPTOSIS INDUCING FACTOR; BETA GALACTOSIDASE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CORTICOSTEROID; CYTOCHROME C; ENVELOPE PROTEIN; FAS ANTIGEN; GLYCOPROTEIN GP 120; INITIATION FACTOR 5A; INTERFERON; MESSENGER RNA; NERVE GROWTH FACTOR; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOIC ACID; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL DEATH; DISEASE COURSE; DRUG EFFECT; GENE EXPRESSION; GENE INDUCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; APOPTOSIS; DIPEPTIDES; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; RETINOIDS; TRANSGLUTAMINASES;

MAMMALIA;

EID: 0036644018     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00077-7     Document Type: Article

References (95)

1. Programmed cell death and AIDS pathogenesis: Significance and potential mechanisms
2. HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by tissue transglutaminase expression and prevented by cyclosporin A
3. Induction of tissue transglutaminase in HIV pathogenesis: Evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues
4. Tissue transglutaminase expression in HIV-infected cells
5. Apoptosis in AIDS
6. Macrophage-colony stimulating factor (M-CSF) stimulation induces cell death in HIV-infected human monocytes
7. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4+ T cells
8. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF5A
9. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation
10. Mapping and sequencing of the murine 'tissue' transglutaminase (Tgm2) gene: Absence of mutations in MRLlpr/lpr mice
11. Differentiation of U937 myelomonocytic cell line by all-trans retinoic acid and 1,25-dihydroxyvitamin D3: Synergistic effects on tissue transglutaminase
12. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection
13. Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling
14. Membrane alterations linked to early interactions of HIV with the cell surface
15. Mitochondrial control of cell death induced by HIV-1-encoded proteins
16. Induction and activation of tissue transglutaminase during programmed cell death
17. Apoptosis: Molecular mechanism in programmed cell death
18. Degradation of cells dying by apoptosis leads to accumulation of epsilon(gamma-glutamyl)lysine isodipeptide in culture fluid and blood
19. Probing the molecular program of apoptosis by cancer chemopreventive agents
20. Transglutaminase induction by various cell death and apoptosis pathways
21. Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells?
22. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
23. Transglutaminases
24. GTP hydrolysis by human tissue transglutaminase homologue
25. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages
26. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV
27. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
28. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases
29. Expression of tissue transglutaminase in BALB-C 3T3 fibroblasts: Effects on cellular morphology and adhesion
30. Chronic activation of the immune system in HIV infection: Contribution to T cell apoptosis and V beta selective T cell anergy
31. Does apoptosis contribute to CD4 T cell depletion in human immunodeficiency virus infection?
32. Apoptosis in AIDS
33. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 cells correlates with lymphocyte activation and with disease progression
34. Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues
35. Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines
36. Presence and possible origin of epsilon(gamma-glutamyl)lysine isodipeptide in human plasma
37. Retinoic acid and its receptors repress expression and transactivation function of nur77: A possible mechanism for the inhibition by retinoic acid
38. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
39. Programmed cell death and extrathymic reduction of Vβ8+CD4+T cells in mice tolerant to Staphylococcus aureus enterotoxin B
40. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase Activity
41. The cytopathic effect of HIV is associated with apoptosis
42. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods
43. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with bcl-2 expression and consequences for AIDS pathogenesis
44. Alteration of tumor necrosis factor-α T cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome
45. GTP hydrolysis by guinea pig liver transglutaminase
46. Mature lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
47. Anergy and apoptosis in CD8+ T cells from HIV-infected persons
48. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen
49. Transglutaminases
50. Human immunodeficiency-virus transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro
51. 'Tissue' transglutaminase in cell death: A downstream or a multifunctional upstream effector?
52. Tissue transglutaminase and apoptosis: Sense and antisense transfection studies in human neuroblastoma cells
53. Programmed death of T cells in HIV-1 infection
54. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
55. Interactions of G(h)/transglutaminase with phospholipase C delta1 and with GTP
56. Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function
57. Mutations in the Fas antigen gene in lpr mice
58. Tissue transglutaminase: An effector in physiologic cell death
59. Identification and characterisation of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter
60. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis
61. Inhibition of tissue transglutaminase increases survival by preventing apoptosis
62. Macrophages as a source of HIV during opportunistic infections
63. New concepts in the immunopathogenesis of human immunodeficiency virus infection
64. Decreased HIV-associated T cell apoptosis by HIV protease inhibitors
65. Tissue transglutaminase: A candidate effector element of physiological cell death
66. Free and protein-conjugated polyamines in mouse epidermal cells
67. Tissue transglutaminase in cells undergoing apoptosis
68. Differential growth of N- and S-type human neuroblastoma cells xenografted into SCID mice. Correlation with apoptosis
69. Lack of tissue transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: Relationship to development of autoimmunity in MRLlpr/lpr mice
70. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis
71. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection
72. Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells
73. Mechanisms of mitochondrial membrane permeabilization
74. Immunopathogenesis of HIV infection
75. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation
76. Syncytium formation amplifies apoptotic signals: A new view on apoptosis in HIV infection in vitro
77. Identification of the eukariotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II
78. Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic cultures
79. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathogenicity
80. A major mechanism of HIV-induced cell killing does not involve cell fusion
81. An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome
82. Apoptosis linked in vivo regulation of the tissue transglutaminase gene promoter
83. Differential expression of tissue transglutaminase in apoptosis of thymocytes induced via distinct signalling pathways
84. Induction of apoptosis by retinoids and RARγ selective compounds in mouse thymocytes through a novel apoptosis pathway
85. Inhibition of activation-induced apoptosis of thymocytes by all-trans and 9-cis retinoic acids is mediated via retinoic acid receptor alpha
86. All-trans retinoic acid inhibition of anti-CD3 induced T cell apoptosis in HIV-infection mostly concerns CD4 T lymphocytes and is mediated via regulation of FAS-L expression
87. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
88. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study
89. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor α and γ and involve nur77 in T cells
90. Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed with vitamin A deficient diet
91. Permeabilization of the mitochondrial inner membrane during apoptosis: Impact of the adenine nucleotide translocator
92. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
93. Requirement for the orphan steroid receptor nur77 in apoptosis of T cell hybridomas
94. 9-cis retinoic acid inhibits activation driven apoptosis: Implications for retinoid X receptor involvement in thymocyte development
95. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells